Robinson Chandler

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Robinson Chandler's trades of Monopar Therapeutics Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
89.38
Quantity 29,056
Value US$2,597,025
Transaction date
Proposed sale
Price
40.00
Quantity 16,800
Value US$672,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-28 2026-09-24
PlS Planned sale
49,186 -11.4%
447.12
US$4,328,470 		49,186 -11.4% 447.12 US$4,328,470
2026-09-28 2026-09-24
PlS Planned sale
96,950 +29.2%
147.03
US$3,552,223 		96,950 +29.2% 147.03 US$3,552,223
2026-09-28 2026-09-24
PlS Planned sale
86,990 -0.7%
356.45
US$193,688 		86,990 -0.7% 356.45 US$193,688
2026-09-28 2026-09-24
PlS Planned sale
10,450 -8.1%
87.15
US$910,718 		10,450 -8.1% 87.15 US$910,718
2026-09-24 2026-09-24
PrS Proposed sale
29,056
89.38
US$2,597,025 		29,056 89.38 US$2,597,025
2025-07-16 2025-07-14
S Sale
16,800 -18.6%
40.00
US$672,020 		16,800 -18.6% 40.00 US$672,020
2025-07-14 2025-07-14
PrS Proposed sale
16,800
40.00
US$672,000 		16,800 40.00 US$672,000